Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer

被引：0
|
作者：
Koji Takada
Shinichiro Kashiwagi
Yuka Asano
Wataru Goto
Rika Kouhashi
Akimichi Yabumoto
Sae Ishihara
Tamami Morisaki
Masatsune Shibutani
Hiroaki Tanaka
Kosei Hirakawa
Masaichi Ohira
机构：
[1] Osaka City University Graduate School of Medicine,Department of Breast and Endocrine Surgery
[2] Osaka City University Graduate School of Medicine,Department of Gastrointestinal Surgery
来源：
BMC Women's Health | / 21卷
关键词：
Hormone receptor-positive breast cancer; Distant metastasis; Recurrence; Tumor-infiltrating lymphocytes; Tumor microenvironment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast Cancer Reply
    Rugo, Hope S.
    Bardia, Aditya
    Tolaney, Sara M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (08) : 1631 - +
  • [32] Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
    Anishka D’Souza
    Darcy Spicer
    Janice Lu
    [J]. Journal of Hematology & Oncology, 11
  • [33] Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
    D'Souza, Anishka
    Spicer, Darcy
    Lu, Janice
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [34] Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer
    Alexander S. Brodsky
    Jinjun Xiong
    Dongfang Yang
    Christoph Schorl
    Mary Anne Fenton
    Theresa A. Graves
    William M. Sikov
    Murray B. Resnick
    Yihong Wang
    [J]. BMC Cancer, 16
  • [35] Prediction of the treatment response to eribulin chemotherapy in breast cancer using tumor-infiltrating lymphocytes
    Kashiwagi, Shinichiro
    Asano, Yuka
    Goto, Wataru
    Kurata, Kento
    Morisaki, Tamami
    Noda, Satoru
    Takashima, Tsutomu
    Onoda, Naoyoshi
    Ohsawa, Masahiko
    Ohira, Masaichi
    Hirakawa, Kosei
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [36] Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer
    Brodsky, Alexander S.
    Xiong, Jinjun
    Yang, Dongfang
    Schorl, Christoph
    Fenton, Mary Anne
    Graves, Theresa A.
    Sikov, William M.
    Resnick, Murray B.
    Wang, Yihong
    [J]. BMC CANCER, 2016, 16
  • [37] Clinicopathologic Evaluation and Prediction Model for Stromal Tumor-Infiltrating Lymphocytes in the Development of Breast Cancer
    Jiang, Jing
    Zhang, Wei
    Zheng, Luya
    Shi, Shenghong
    Li, Xujun
    Sun, Long
    Ge, Qidong
    Li, Chao
    Lin, Hui
    [J]. ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, 2019, 41 (04): : 119 - 126
  • [38] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Iwase, Hirotaka
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (02) : 249 - 252
  • [39] Validation of a prognostic model integrating Breast Cancer Index (BCI) with tumor size and grade for prediction of distant recurrence in hormone receptor-positive (HR plus ) breast cancer with 1-3 positive nodes.
    Zhang, Yi
    Jerevall, Piiha-Lotta
    Schroeder, Brock
    Nolan, Hannah
    Ly, Amy
    Schnabel, Catherine A.
    Sgroi, Dennis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Iwase, Hirotaka
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 27 - 27
12345